ADMA
NASDAQ · Biotechnology
Adma Biologics Inc
$8.17
-0.30 (-3.54%)
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+331.1% upside
Low Target
$21.76
Average Target
$35.22
High Target
$46.82
Current Price
$8.17
Current
$8.17
$8.17
Target
$35.22
$35.22
$21.76
$35.22 avg
$46.82
Scenario Analysis
Bear Case
$21.76
166.3%
Low target
Base Case
$35.22
+331.1%
Avg target
Bull Case
$46.82
+473.1%
High target
Risk/Reward
2.8x
Favorable
Price in Context
52-Week High
$23.98
-65.9% from high
52-Week Low
$7.21
+13.3% from low
50-Day SMA
$17.86
-54.3% vs SMA
200-Day SMA
$17.61
-53.6% vs SMA
RSI (14)
42.2
Neutral
Target vs 52W High
$35.22
+46.9% vs high
Next Earnings Report
May 13, 2026
2d
until earnings
EPS Est: $0.20
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 40 | 75% | $257.58 | +27.8% |
| AMGN | Hold | 44 | 48% | $190.87 | -42.5% |
| GILD | Strong Buy | 39 | 79% | $362.68 | +176.2% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | +2.0% |
| REGN | Strong Buy | 38 | 79% | $76.80 | -89.3% |
| ALNY | Strong Buy | 36 | 75% | $102.31 | -65.3% |
| RVMD | Strong Buy | 27 | 96% | $114.11 | -19.5% |
| INSM | Strong Buy | 28 | 96% | $143.40 | +41.5% |